PRO-LIGAND - AN APPROACH TO DE-NOVO MOLECULAR DESIGN .4. APPLICATION TO THE DESIGN OF PEPTIDES

被引:28
作者
FRENKEL, D [1 ]
CLARK, DE [1 ]
LI, J [1 ]
MURRAY, CW [1 ]
ROBSON, B [1 ]
WASZKOWYCZ, B [1 ]
WESTHEAD, DR [1 ]
机构
[1] PROTEUS MOLEC DESIGN LTD,MACCLESFIELD SK11 0JL,CHESHIRE,ENGLAND
关键词
COMPUTER-AIDED MOLECULAR DESIGN; DE NOVO PEPTIDE DESIGN; HIV-1 PROTEASE INHIBITORS; LYSOZYME EPITOPES; SYNTHETIC VACCINE DESIGN;
D O I
10.1007/BF00124453
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In some instances, peptides can play an important role in the discovery of lead compounds. This paper describes the peptide design facility of the de novo drug design package, PRO_LIGAND. The package provides a unified framework for the design of peptides that are similar or complementary to a specified target. The approach uses single amino acid residues, selected from preconstructed libraries of different residues and conformations, and places them on top of predefined target interaction sites. This approach is a well-tested methodology for the design of organics but has not been used for peptides before. Peptides represent a difficulty because of their great conformational flexibility and a study of the advantages and disadvantages of this simple approach is an important step in the development of design tools. After a description of our general approach, a more detailed discussion of its adaptation to peptides is given. The method is then applied to the design of peptide-based inhibitors to HIV-1 protease and the design of structural mimics of the surface region of lysozyme. The results are encouraging and point the way towards further development of interaction site-based approaches for peptide design.
引用
收藏
页码:213 / 225
页数:13
相关论文
共 67 条
[1]   CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTER - COMPUTER-BASED SEARCH, RETRIEVAL, ANALYSIS AND DISPLAY OF INFORMATION [J].
ALLEN, FH ;
BELLARD, S ;
BRICE, MD ;
CARTWRIGHT, BA ;
DOUBLEDAY, A ;
HIGGS, H ;
HUMMELINK, T ;
HUMMELINKPETERS, BG ;
KENNARD, O ;
MOTHERWELL, WDS ;
RODGERS, JR ;
WATSON, DG .
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 1979, 35 (OCT) :2331-2339
[2]  
Appelt Krzysztof, 1993, Perspectives in Drug Discovery and Design, V1, P23, DOI 10.1007/BF02171654
[3]  
Ball J., 1990, CHEM STRUCTURE INFOR, P107
[4]   MULTIPLE HIGHLY DIVERSE STRUCTURES COMPLEMENTARY TO ENZYME BINDING-SITES - RESULTS OF EXTENSIVE APPLICATION OF A DE-NOVO DESIGN METHOD INCORPORATING COMBINATORIAL GROWTH [J].
BOHACEK, RS ;
MCMARTIN, C .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1994, 116 (13) :5560-5571
[5]   LUDI - RULE-BASED AUTOMATIC DESIGN OF NEW SUBSTITUENTS FOR ENZYME-INHIBITOR LEADS [J].
BOHM, HJ .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1992, 6 (06) :593-606
[6]   THE COMPUTER-PROGRAM LUDI - A NEW METHOD FOR THE DENOVO DESIGN OF ENZYME-INHIBITORS [J].
BOHM, HJ .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1992, 6 (01) :61-78
[7]   ON THE USE OF LUDI TO SEARCH THE FINE CHEMICALS DIRECTORY FOR LIGANDS OF PROTEINS OF KNOWN 3-DIMENSIONAL STRUCTURE [J].
BOHM, HJ .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1994, 8 (05) :623-632
[9]  
BOHM HJ, 1993, 3D QSAR DRUG DESIGN, P386
[10]  
BRINT AT, 1987, J MOL GRAPHICS, V5, P49